| Year |
Citation |
Score |
| 2023 |
Mizuno Y, Ashok AH, Bhat BB, Jauhar S, Howes OD. Dopamine in major depressive disorder: A systematic review and meta-analysis of in vivo imaging studies. Journal of Psychopharmacology (Oxford, England). 2698811231200881. PMID 37811803 DOI: 10.1177/02698811231200881 |
0.416 |
|
| 2023 |
Shatalina E, Ashok AH, Wall MB, Nour MM, Myers J, Reis Marques T, Rabiner EA, Howes OD. Reward processing in schizophrenia and its relation to Mu opioid receptor availability and negative symptoms: A [C]-carfentanil PET and fMRI study. Neuroimage. Clinical. 39: 103481. PMID 37517175 DOI: 10.1016/j.nicl.2023.103481 |
0.581 |
|
| 2022 |
Erritzoe D, Godlewska BR, Rizzo G, Searle GE, Agnorelli C, Lewis Y, Ashok AH, Colasanti A, Boura I, Farrell C, Parfitt H, Howes O, Passchier J, Gunn RN, Politis M, et al. Brain Serotonin Release Is Reduced in Patients With Depression: A [C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge. Biological Psychiatry. PMID 36635177 DOI: 10.1016/j.biopsych.2022.10.012 |
0.419 |
|
| 2021 |
Rogdaki M, Devroye C, Ciampoli M, Veronese M, Ashok AH, McCutcheon RA, Jauhar S, Bonoldi I, Gudbrandsen M, Daly E, van Amelsvoort T, Van Den Bree M, Owen MJ, Turkheimer F, Papaleo F, et al. Correction: Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study. Molecular Psychiatry. PMID 34158623 DOI: 10.1038/s41380-021-01192-0 |
0.434 |
|
| 2021 |
Rogdaki M, Devroye C, Ciampoli M, Veronese M, Ashok A, McCutcheon RA, Jauhar S, Bonoldi I, Gudbrandsen M, Daly E, van Amelsvoort T, Van Den Bree M, Owen MJ, Turkheimer F, Papaleo F, et al. Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study. Molecular Psychiatry. PMID 33981004 DOI: 10.1038/s41380-021-01108-y |
0.502 |
|
| 2021 |
Ashok AH, Myers J, Frost G, Turton S, Gunn RN, Passchier J, Colasanti A, Marques TR, Nutt D, Lingford-Hughes A, Howes OD, Rabiner EA. Acute acetate administration increases endogenous opioid levels in the human brain: A [C]carfentanil molecular imaging study. Journal of Psychopharmacology (Oxford, England). 269881120965912. PMID 33406950 DOI: 10.1177/0269881120965912 |
0.434 |
|
| 2020 |
Marques TR, Ashok AH, Angelescu I, Borgan F, Myers J, Lingford-Hughes A, Nutt DJ, Veronese M, Turkheimer FE, Howes OD. GABA-A receptor differences in schizophrenia: a positron emission tomography study using [C]Ro154513. Molecular Psychiatry. PMID 32296127 DOI: 10.1038/S41380-020-0711-Y |
0.623 |
|
| 2020 |
Howes O, Ashok A, Shatalina E, Rabiner E, Marques TR. O5.5. The Neurobiology Of Negative Symptoms In Schizophrenia: Multi-Modal Pet And Fmri Findings Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa028.028 |
0.693 |
|
| 2019 |
Alameda L, Ashok A, Avery S, Bani-Fatemi A, Berkhout S, Best M, Bonfils K, Colizzi M, Dauvermann M, Plessis SD, Dwyer D, Eisner E, Ganesh S, Hernaus D, Ithal D, et al. The 2019 Schizophrenia International Research Society Conference, 10-14 April, Orlando, Florida: A summary of topics and trends. Psychiatry Research. 112672. PMID 31780184 DOI: 10.1016/J.Psychres.2019.112672 |
0.308 |
|
| 2019 |
Erritzoe D, Ashok AH, Searle GE, Colasanti A, Turton S, Lewis Y, Huiban M, Moz S, Passchier J, Saleem A, Beaver J, Lingford-Hughes A, Nutt DJ, Howes OD, Gunn RN, et al. Serotonin release measured in the human brain: a PET study with [C]CIMBI-36 and d-amphetamine challenge. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31715617 DOI: 10.1038/S41386-019-0567-5 |
0.491 |
|
| 2019 |
Ashok AH, Myers J, Reis Marques T, Rabiner EA, Howes OD. Reduced mu opioid receptor availability in schizophrenia revealed with [C]-carfentanil positron emission tomographic Imaging. Nature Communications. 10: 4493. PMID 31582737 DOI: 10.1038/S41467-019-12366-4 |
0.663 |
|
| 2019 |
Mehta UM, Ashok AH, Thirthalli J, Keshavan MS. Early motor resonance differentiates schizophrenia patients from healthy subjects and predicts social cognition performance. Progress in Brain Research. 247: 353-374. PMID 31196441 DOI: 10.1016/Bs.Pbr.2019.03.011 |
0.332 |
|
| 2019 |
Ashok AH, Mizuno Y, Howes OD. Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies. Psychopharmacology. PMID 30887059 DOI: 10.1007/S00213-019-05196-1 |
0.416 |
|
| 2019 |
Marques TR, Ashok A, Veronese M, Ureche-Angelescu I, Borgan F, Rabiner E, Howes O. O7.6. GABAA RECEPTOR AVAILABILITY IN PATIENTS WITH SCHIZOPHRENIA: A PET STUDY USING [11C]-RO15 Schizophrenia Bulletin. 45: S181-S182. DOI: 10.1093/Schbul/Sbz021.230 |
0.708 |
|
| 2019 |
Howes O, Ashok A, Pepper F, Jauhar S, Marques TR. F80. THE NEUROBIOLOGY OF NEGATIVE SYMPTOMS: PET AND MR IMAGING FINDINGS IN FIRST EPISODE AND CHRONIC SCHIZOPHRENIA Schizophrenia Bulletin. 45: S284-S284. DOI: 10.1093/Schbul/Sbz018.492 |
0.565 |
|
| 2018 |
Marques TR, Ashok AH, Pillinger T, Veronese M, Turkheimer FE, Dazzan P, Sommer IEC, Howes OD. Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies. Psychological Medicine. 1-11. PMID 30355368 DOI: 10.1017/S0033291718003057 |
0.598 |
|
| 2018 |
Plavén-Sigray P, Matheson GJ, Collste K, Ashok AH, Coughlin JM, Howes OD, Mizrahi R, Pomper MG, Rusjan P, Veronese M, Wang Y, Cervenka S. Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data. Biological Psychiatry. PMID 29653835 DOI: 10.1016/J.Biopsych.2018.02.1171 |
0.571 |
|
| 2018 |
Kokkinou M, Ashok AH, Howes OD. The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders. Molecular Psychiatry. 23: 59-69. PMID 28972576 DOI: 10.1038/Mp.2017.190 |
0.405 |
|
| 2017 |
Ashok AH, Mizuno Y, Volkow ND, Howes OD. Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis. Jama Psychiatry. PMID 28297025 DOI: 10.1001/Jamapsychiatry.2017.0135 |
0.452 |
|
| 2017 |
Ashok AH, Marques TR, Jauhar S, Nour MM, Goodwin GM, Young AH, Howes OD. The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment. Molecular Psychiatry. PMID 28289283 DOI: 10.1038/Mp.2017.16 |
0.37 |
|
| 2017 |
Ashok AH, Marques T, Rabiner E, Howes O. Mu-opioid receptor availability in schizophrenia patients: a PET study using [11C]-carfentanil European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31615-2 |
0.698 |
|
| 2016 |
Bloomfield MA, Ashok AH, Volkow ND, Howes OD. The effects of Δ(9)-tetrahydrocannabinol on the dopamine system. Nature. 539: 369-377. PMID 27853201 DOI: 10.1038/Nature20153 |
0.464 |
|
| 2016 |
Ganesh S, Ashok AH, Kumar CN, Thirthalli J. Prevalence and determinants of metabolic syndrome in patients with schizophrenia: A systematic review and meta-analysis of Indian studies. Asian Journal of Psychiatry. 22: 86-92. PMID 27520904 DOI: 10.1016/J.Ajp.2016.05.006 |
0.37 |
|
| 2016 |
Bloomfield M, Howes O, Ashok A, Volkow N. Neuropsychopharmacology in human cannabis users: findings from molecular imaging European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)30878-1 |
0.346 |
|
| 2012 |
Ashok AH, Baugh J, Yeragani VK. Paul Eugen Bleuler and the origin of the term schizophrenia (SCHIZOPRENIEGRUPPE). Indian Journal of Psychiatry. 54: 95-6. PMID 22556451 DOI: 10.4103/0019-5545.94660 |
0.383 |
|
| Show low-probability matches. |